Multiple myeloma treatment options

Multiple myeloma is a malignant tumor originating from plasma cells in the bone marrow. It is characterized by an increase in abnormal plasma cells and often leads to symptoms such as bone pain, anemia, and renal insufficiency. In response to this disease, a variety of treatment options have been developed in medicine, aiming to prolong the survival period and improve the quality of life of patients.

1. Chemotherapy

Chemotherapy is the first choice for the treatment of multiple myeloma, using cytotoxic drugs to kill or inhibit the growth of tumor cells. Commonly used chemotherapy drugs include melphalan, cyclophosphamide, bortezomib, etc. Among them, bortezomib, as a proteasome inhibitor, has been widely used in the treatment of multiple myeloma. It can significantly improve the response rate and survival time of patients.

2. Hematopoietic stem cell transplantation

Hematopoietic stem cell transplantation is an effective treatment for eligible patients. Before transplantation, patients will receive high-intensity chemotherapy to eliminate tumor cells in the body, and then infuse autologous or allogeneic hematopoietic stem cells to rebuild the blood system. Autologous hematopoietic stem cell transplantation is widely used in young patients who are suitable for intensive chemotherapy because of its non-rejection reaction and high safety.

3. Immunomodulators and targeted therapy

Immunomodulators such as lenalidomide and thalidomide can enhance the anti-tumor effect of the immune system. Targeted therapy targets specific genes or proteins of tumor cells, such as CD38 monoclonal antibodies and other new drugs, providing more options for the treatment of multiple myeloma.

4. Supportive treatment

During the treatment process, patients also need to receive supportive care to relieve symptoms and improve quality of life. This includes blood transfusions to improve anemia, bisphosphonates to treat hypercalcemia, and kidney dialysis when necessary.

To sum up, the treatment plan for multiple myeloma needs to be formulated according to the specific situation of the patient, and usually involves chemotherapy, hematopoietic stem cell transplantation, immunomodulators, targeted therapy, and supportive care. As medicine continues to advance, the emergence of new drugs and new technologies will bring more hope and possibilities to patients.

(Common multiple myeloma treatment drugs include: melphalan, melphalan, bortezomib, ixazomib, etc. For specific drug details, please see the website homepage or click for consultation.)